Medicine and Dentistry
Interstitial Lung Disease
100%
Myositis
50%
Dermatomyositis
26%
Disease
26%
Idiopathic Pulmonary Fibrosis
20%
Rheumatoid Arthritis
18%
Rheumatology
15%
Antisynthetase Syndrome
14%
Pulmonary Fibrosis
13%
Polymyositis
13%
Autoantibodies
12%
Diagnosis
11%
Symptom
10%
Silo-Filler's Disease
10%
Lung Biopsy
10%
Quality of Life
9%
Clinical Trial
9%
Forced Vital Capacity
8%
Autoimmune Rheumatic Disease
8%
Connective Tissue Disease
8%
Placebo
8%
Pneumonia
7%
Symptomatic Treatment
7%
Clinician
7%
Myopathy
7%
Treatment of Interstitial Lung Disease
7%
Disease Exacerbation
6%
Dyspnea
5%
Pirfenidone
5%
Lung Transplantation
5%
Immune Checkpoint Inhibitor
5%
Keyphrases
Interstitial Lung Disease
64%
Dermatomyositis
26%
Myositis
22%
Autoantibodies
21%
Idiopathic Pulmonary Fibrosis
15%
Idiopathic Inflammatory Myopathies
14%
Rheumatoid Arthritis
13%
Pulmonary Fibrosis
12%
Checkpoint Inhibitor Pneumonitis
12%
Inositol 1,4,5-trisphosphate Receptor (IP3R)
11%
Rheumatoid Arthritis-associated Interstitial Lung Disease
10%
Antisynthetase Syndrome
9%
American College of Rheumatology
8%
American College of Chest Physicians
8%
Systemic Autoimmune Rheumatic Diseases
8%
Polymyositis
8%
Clinical Features
7%
Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
7%
Palliative Care
7%
Pirfenidone
7%
Transbronchial Lung Biopsy
6%
Alternative Splicing
6%
Peripheral Tissues
6%
Forced Vital Capacity
5%
Phosphorylation
5%
Non-small Cell Lung Cancer (NSCLC)
5%
Severe Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Interstitial Lung Disease
57%
Myositis
29%
Fibrosing Alveolitis
21%
Disease
14%
Autoantibodies
13%
Antisynthetase Syndrome
13%
Dermatomyositis
11%
Lung Disease
7%
Myopathy
7%
Clinical Trial
7%
Polymyositis
6%
Lung Fibrosis
6%
Immunotherapy
6%
Pneumonia
5%
Placebo
5%
Rheumatic Disease
5%
